NumerixS Investment Technologies’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-4,594
Closed -$373K 334
2020
Q2
$373K Buy
4,594
+4,494
+4,494% +$362K 0.1% 231
2020
Q1
$7K Sell
100
-5,457
-98% -$419K ﹤0.01% 917
2019
Q4
$434K Sell
5,557
-15,043
-73% -$1.08M 0.09% 263
2019
Q3
$1.31M Buy
20,600
+16,100
+358% +$1.42M 0.34% 55
2019
Q2
$388K Sell
4,500
-38,098
-89% -$2.91M 0.11% 229
2019
Q1
$3.14M Buy
+42,598
New +$2.36M 0.42% 44

Other funds holding GH

NumerixS Investment Technologies's GH Position: Q3 2020 in Review

NumerixS Investment Technologies sold out of Guardant Health (GH) in Q3 2020, closing a stake of 4,594 shares — an estimated $373K sold.

NumerixS Investment Technologies first reported a position in GH in Q1 2019 and held it in 6 quarters. The position peaked at $3.14M in Q1 2019. 345 funds tracked by Wall St. Rank hold GH as of Q3 2020.

  • NumerixS Investment Technologies reported no remaining Guardant Health position as of Q3 2020 after selling out during the quarter.
  • NumerixS Investment Technologies sold 4,594 Guardant Health shares in Q3 2020, an estimated $373K.
  • NumerixS Investment Technologies first reported a position in Guardant Health in Q1 2019 and held it in 6 quarters.
  • NumerixS Investment Technologies's Guardant Health position peaked at $3.14M in Q1 2019.
  • 345 funds tracked by Wall St. Rank held Guardant Health as of Q3 2020.

Based on NumerixS Investment Technologies's 13F filing for Q3 2020.